Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

States’ Limits On OTC Dextromethorphan Sales Could Force Congress’ Hand

Executive Summary

US House legislation banning the sale of DXM OTCs to consumers under age 18 likely stands the same chance right now as previous versions that have failed, but CHPA expects an increasing number of state laws could spur future action.

Advertisement

Related Content

Industry Roundup: Warning Letters, DXM Bill, Nutrition Label Update
DXM Sales Age Restriction Reaches Florida; CHPA Navigates PSE Road
To Curb PSE Diversion, Retailers Lead By Example With Emphasis On Tamper-Resistant Products
FDA Panel Says Leave DXM Unscheduled For Now, Urges Congressional Action
Combat Meth Act Compliance Can Trip Up Drug Retailers

Topics

Advertisement
UsernamePublicRestriction

Register

PS120189

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel